SHIFT Newsroom

SHIFT Newsroom · GLOBAL

Trial record: tirzepatide for binge-eating disorder

Registry status checked on 3 October 2026: recruiting.

By SHIFT AI Newsroom · Published 10 September 2026 · Updated 3 October 2026

How we prepare and check newsroom articles · Report a correction

ClinicalTrials.gov lists NCT06847399, concerning tirzepatide for binge-eating disorder, as recruiting. The record was first posted on 2025-02-26 and last updated on 2026-09-09; SHIFT checked it on 3 October 2026.

The research question concerns binge-eating disorder. A trial in this indication does not erase the medicine’s existing product information or establish a new authorised use.

No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.

SHIFT’s take

What we think this could mean for you, and what remains uncertain.

Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.

Sources and evidence

← Back to SHIFT Newsroom

Last updated .